The study, published in the journal Gastroenterology, found that patients with short-term SSRI exposure had a greater risk of GI bleeding. The only SSRIs linked to GI bleeding risk were fluoxetine and sertraline.
The risk was not found in patients taking drugs in other antidepressant classes such as tricyclic antidepressants, monoamine oxidase inhibitors and serotonin and norepinephrine reuptake inhibitors.
The risk of bleeding increased when SSRIs were combined with non-steroidal anti-inflammatory drugs.
More articles on gastroenterology:
FDA grants tentative approval of UCERIS for ulcerative colitis
6 gastroenterologists making headlines
Solos Endoscopy to expand device distribution to Canada
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
